First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial.

TPS3618Background: Approximately 60% of colorectal cancer (CRC) patients are ≥ 70 years, of whom 50-60% already have metastasis at the time of diagnosis. Available data indicate that elderly patien...